The immune checkpoint molecule CTLA-4 demonstrated significant positive correlations with HJURP, VGF and COMP expression (p < 0.05; Fig. 6E), suggesting potential coordinated regulation of immune evasion and tumor progression pathways. The gene discussed is CTLA4; the disease is neoplasm.